Combined Immunotherapy and Radiosurgery for Metastatic Colorectal Cancer
Status:
Unknown status
Trial end date:
2021-05-31
Target enrollment:
Participant gender:
Summary
A single institution study to evaluate the safety and tolerability of the combination
treatment of nivolumab, ipilimumab, CMP-001 and radiosurgery in patients with metastatic
colorectal cancer with liver metastases.